Continued Sales Growth for PHI

Phase Holographic Imaging’s sales in November – January gained 240 % and amounted to 2.7 (0.8) MSEK. Sales over the past four fiscal quarters (Feb 2021 – Jan 2022) amount to 8.8 (2.3) MSEK. Further details will be provided in Interim Report 3 2021/22 on March 23.

The rapid sales growth results from the strategic decision to focus on online sales & marketing in response to the accelerated digitalization. The decision was first communicated in March two years ago in Interim Report 3 2019/20 and further communicated in year-end report for 2019/20.

It is expected that sales will continue to grow as the company’s online sales & marketing is further developed.

For additional information, please contact:
Peter Egelberg
E-mail: ir@phiab.se
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.